Method for detecting whether patient is allergic to medicine
A drug and allergy technology, applied in the field of detecting whether a patient is allergic to drugs, can solve the problems of lack of standard operating methods for large-sample clinical verification, low sensitivity, and no commercial kits for sale.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
[0023] A 27-year-old male was taking quadruple anti-tuberculosis therapy of rifampicin, isoniazid, pyrazinamide and ethambutol for left upper pulmonary tuberculosis. Two weeks after taking the medicine, measles-like erythema appeared on the trunk and extremities, accompanied by obvious itching. After being diagnosed as "drug eruption", all drugs were stopped and the rash subsided after 1 week of antiallergic treatment. According to this method, it was confirmed by drug skin patch test that among the four drugs, they were allergic to rifampicin. After taking isoniazid, pyrazinamide and ethambutol to continue anti-tuberculosis treatment, no rash appeared again.
[0024] case two
[0025] Female, 44 years old, took rifampicin, isoniazid, pyrazinamide, ethambutol anti-tuberculosis treatment for tuberculous pleurisy. One month after taking the medicine, measles-like erythema appeared on the trunk and extremities, and later developed into erythroderma with abnormal liver function...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com